文献速递重症综合管理与镇静镇痛心脑血管急症

神经外科术后拔除引流管后高热危险因素分析

[Analysis of risk factors of hyperpyrexia suffered by post neurosurgical patients after removal of drainage tube].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论神经外科术后拔除引流管后出现体温≥39℃的高热,与ICU住院时间延长和院内死亡率升高相关。

该研究回顾性分析2019年1月至2021年7月北京大学第三医院重症医学科收治的146例神经外科术后留置引流管患者,按拔管后24小时内体温是否≥39℃分为高热组(28例)与非高热组,并基于格拉斯哥昏迷评分(GCS)进行倾向性评分匹配(每组28例)。匹配后高热组脑室引流管留置比例[32.1%(9/28)vs. 7.1%(2/28),P<0.05]和腰椎穿刺比例[25.0%(7/28)vs. 0(0/28),P<0.05]均显著高于非高热组。高热组ICU住院时间[17.0(8.0, 32.3)天 vs. 8.5(1.0, 16.8)天,P<0.05]、院内死亡率[35.7%(10/28)vs. 10.7%(3/28),P<0.05]及住院期间碳青霉烯类耐药菌培养阳性率[32.1%(9/28)vs. 3.6%(1/28),P<0.05]均显著高于非高热组。作者认为拔管后高热可能与颅内引流管继发感染、拔管致细菌颅内播散及引流管相关颅内多重耐药菌感染有关。

要点

  • 神经外科术后拔除引流管后24小时内体温≥39℃者占28/146,高热组ICU住院时间17.0(8.0, 32.3)天 vs. 非高热组8.5(1.0, 16.8)天,P<0.05。
  • 高热组院内死亡率35.7%(10/28)vs. 非高热组10.7%(3/28),P<0.05,死亡风险明显升高。
  • 匹配后高热组脑室引流管留置比例32.1%(9/28)vs. 7.1%(2/28),P<0.05;腰椎穿刺比例25.0%(7/28)vs. 0(0/28),P<0.05。
  • 高热组住院期间碳青霉烯类耐药菌培养阳性率32.1%(9/28)vs. 3.6%(1/28),P<0.05,显著高于非高热组。
  • 拔管前1天白细胞计数[13.0(9.5, 15.2)×10⁹/L vs. 11.5(8.8, 13.3)×10⁹/L]、拔管后中性粒细胞比例[0.892(0.826, 0.922)vs. 0.843(0.809, 0.909)]及引流液/管端培养阳性率[7.1%(2/28)vs. 0(0/28)]在高热组升高,但差异无统计学意义。

适用人群与场景

  • 2019年1月至2021年7月北京大学第三医院重症医学科收治的神经外科术后留置引流管的146例患者。
  • 纳入标准:神经外科术后留置引流管并入住重症医学科。

诊断标准与关键阈值

  • 高热组:拔除引流管后24小时内体温≥39℃;非高热组:拔除引流管后24小时内体温<39℃。
  • 倾向性评分匹配:基于格拉斯哥昏迷评分(GCS)进行匹配,匹配后每组各28例。

红旗征与不能漏的情况

  • 拔除引流管后24小时内体温≥39℃,提示ICU住院时间延长(17.0天 vs. 8.5天,P<0.05)和院内死亡率升高(35.7% vs. 10.7%,P<0.05)。
  • 留置脑室引流管者拔管后高热比例更高[32.1%(9/28)vs. 7.1%(2/28),P<0.05]。
  • 住院期间碳青霉烯类耐药菌培养阳性者拔管后高热比例更高[32.1%(9/28)vs. 3.6%(1/28),P<0.05]。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量146例;单中心(北京大学第三医院重症医学科);人群为神经外科术后留置引流管患者。
  • 高热组28例(19.2%),非高热组118例;倾向性评分匹配后两组各28例。
  • 匹配后两组性别、年龄、GCS评分及高血压、糖尿病比例差异无统计学意义。
  • 入院主要疾病为脑出血(53.6%,30/56)。
  • 匹配后高热组脑室引流管留置比例32.1%(9/28)vs. 7.1%(2/28),P<0.05;腰椎穿刺比例25.0%(7/28)vs. 0(0/28),P<0.05;其他引流管位置两组差异无统计学意义。
  • 拔管前1天白细胞计数[13.0(9.5, 15.2)×10⁹/L vs. 11.5(8.8, 13.3)×10⁹/L]、拔管后中性粒细胞比例[0.892(0.826, 0.922)vs. 0.843(0.809, 0.909)]及引流液/管端培养阳性率[7.1%(2/28)vs. 0(0/28)]高热组升高,但差异无统计学意义。
  • 拔管前肺部、泌尿系统及血流感染比例两组差异无统计学意义。
  • 主要结局:高热组ICU住院时间17.0(8.0, 32.3)天 vs. 非高热组8.5(1.0, 16.8)天,P<0.05;院内死亡率35.7%(10/28)vs. 10.7%(3/28),P<0.05。

证据类型、等级与局限

  • 证据类型:回顾性分析(单中心)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 神经外科术后拔除引流管后24小时内出现体温≥39℃的患者,ICU住院时间显著延长(17.0天 vs. 8.5天,P<0.05),院内死亡率显著升高(35.7% vs. 10.7%,P<0.05)。
  • 作者认为拔管后高热可能与颅内引流管继发感染、拔管致细菌颅内播散及引流管相关颅内多重耐药菌感染有关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the risk factors of hyperthermia after removal of drainage tubes in patients after neurosurgery.

METHODS: The clinical data of 146 patients after neurosurgery with indwelling drainage tubes admitted to the department of critical care medicine of Pecking University Third Hospital from January 2019 to July 2021 were analyzed retrospectively. The patients were divided into hyperthermia group (body temperature ≥ 39 centigrade) and non-hyperthermia group (body temperature < 39 centigrade) according to whether their body temperatures within 24 hours after removal of drainage tubes. General clinical data and outcomes of the two groups were collected, and different tendentious scores were matched with the hyperthermia group and non-hyperthermia group based on Glasgow coma score (GCS), respectively. After such matching, the clinical baseline characteristics [age, gender, admission diagnosis, major complications, acute physiology and chronic health evaluation II (APACHE II) at admission, GCS], number of days of drainage tubes retention, location of drainage tubes, microbial culture results before removal of drainage tubes, white blood cell (WBC) and neutrophil ratio (NEU%) before and after removal of drainage tubes as well as clinical outcomes of the cohort patients were analyzed. The primarily outcome was in-hospital mortality, and then the length of intensive care unit (ICU) stay.

RESULTS: A total of 146 patients after neurosurgery were included, 28 of which developed hyperthermia after removal of drainage tubes. The GCS scores at admission in the hyperthermia group were significantly lower than that in the non-hyperthermia group, while the proportion of hypertension and diabetes in the hyperthermia group was significantly higher than that in the non-hyperthermia group. Based on GCS scores, the two groups, each of which included 28 patients, were matched with tendentious scores, and there was no significant difference in gender, age, GCS scores and the proportion of hypertension and diabetes between the two groups. The main disease for patients upon admission was cerebral hemorrhage (53.6%, 30/56). The proportion of indwelling ventricular drainage tube retention in the hyperthermia group was significantly higher than that in the non-hyperthermia group [32.1% (9/28) vs. 7.1% (2/28), P < 0.05], but there was no significant difference in the location of other drainage tubes between the two groups. The proportion of lumbar puncture in the hyperthermia group was also significantly higher than that in the non-hyperthermia group [25.0% (7/28) vs. 0 (0/28), P < 0.05]. Compared with the non-hyperthermia group, WBC [×109/L: 13.0 (9.5, 15.2) vs. 11.5 (8.8, 13.3)] of 1 day before removal of drainage tubes, NEU% [0.892 (0.826, 0.922) vs. 0.843 (0.809, 0.909)] after removal of drainage tubes and positive rate of drainage-fluid culture or drainage-tube-tip culture [7.1% (2/28) vs. 0% (0/28)] in the hyperthermia group increased, but there were not significant differences. There was no significant difference in the proportion of pulmonary, urinary system and blood flow infection before removal of drainage tubes in the two groups. In terms of primary outcomes, compared with the non-hyperthermia group, the length of ICU stay [days: 17.0 (8.0, 32.3) vs. 8.5 (1.0, 16.8), P < 0.05] in the hyperthermia group was significantly prolonged, and the in-hospital mortality [35.7% (10/28) vs. 10.7% (3/28), P < 0.05] in the hyperthermia group was obviously increased. The positive rate of carbapenem-resistant bacteria culture [32.1% (9/28) vs. 3.6% (1/28), P < 0.05] in the hyperthermia group during hospitalization was significantly higher than that in the non-hyperthermia group.

CONCLUSIONS: Hyperthermia after removal of drainage tubes for patients after neurosurgery can significantly prolong the length of ICU stay and increase the in-hospital mortality, which may be related to the secondary infection caused by indwelling intracranial drainage tubes and the intracranial spread of bacteria caused by removal of drainage tubes, as well as the intracranial multidrug-resistant bacterial infection caused by the drainage tubes.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Bo S, Zheng J, Xi J, et al. [Analysis of risk factors of hyperpyrexia suffered by post neurosurgical patients after removal of drainage tube]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36473566. doi:10.3760/cma.j.cn121430-20220426-00418

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。